Launch of the AJTMH Supplement on IDA & Other Innovations
Updated: Apr 1, 2022
We are excited to share the American Journal of Tropical Medicine and Hygiene Supplement on the introduction of IDA (Triple Drug Therapy for Lymphatic Filariasis) and other innovations in NTDs and global health more broadly, which include articles authored by Drugs for Neglected Diseases Initiative, The Taskforce for Global Health, Washington University of St. Louis, WHO, Bill & Melinda Gates Foundation, PATH, and Bruyère.
Below are two articles Dr. Krentel co-authored with her colleagues:
Lessons from Large-Scale Tolerability and Acceptability Studies of Triple Drug Mass Drug Administration Performed to Support Policy Change and Accelerate Elimination of Lymphatic Filariasis
Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole